Sone Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.14M Buy
+13,292
New +$4.93M 0.39% 77
2025
Q1
Sell
-6,261
Closed -$2.31M 125
2024
Q4
$2.31M Buy
+6,261
New +$2.62M 0.29% 93

Other funds holding ELV

Sone Capital Management's ELV Position: Q2 2026 in Review

Sone Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 13,292 shares worth $5.14M. The stake represents 0.39% of the portfolio and ranks #77 among its holdings. This is a return to the name: Sone Capital Management previously reported a position in ELV as recently as Q4 2024.

Sone Capital Management first reported a position in ELV in Q4 2024 and has held it in 2 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sone Capital Management held 13,292 shares of Elevance Health worth $5.14M as of Q2 2026.
  • Elevance Health was a new Sone Capital Management position in Q2 2026.
  • Elevance Health made up 0.39% of Sone Capital Management's portfolio in Q2 2026, its #77 holding.
  • Sone Capital Management first reported a position in Elevance Health in Q4 2024 and has held it in 2 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.